These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 261582)

  • 41. Particulate contamination and stability of three additives in 0.9% sodium chloride injection in plastic and glass large-volume containers.
    Stokes TF; Sumner ED; Needham TE
    Am J Hosp Pharm; 1975 Aug; 32(8):821-6. PubMed ID: 1146840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Theoretical aspects of particulate matter monitoring by microscopic and instrumental methods.
    Schroeder HG; Deluca PP
    J Parenter Drug Assoc; 1980; 34(3):183-91. PubMed ID: 6901774
    [No Abstract]   [Full Text] [Related]  

  • 43. Automated particulate detection for ampuls with use of the probabilistic particulate detection model.
    Knapp JZ; Kushner HK; Abramson LR
    J Parenter Sci Technol; 1981; 35(1):21-35. PubMed ID: 7229827
    [No Abstract]   [Full Text] [Related]  

  • 44. Particulate matter in parenteral products: a review.
    Borchert SJ; Abe A; Aldrich DS; Fox LE; Freeman JE; White RD
    J Parenter Sci Technol; 1986; 40(5):212-41. PubMed ID: 3540253
    [No Abstract]   [Full Text] [Related]  

  • 45. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plastic i.v. container for nitroglycerin.
    Amann AH; Baaske DM; Wagenknecht DM
    Am J Hosp Pharm; 1980 May; 37(5):618. PubMed ID: 6770680
    [No Abstract]   [Full Text] [Related]  

  • 48. Determination of particulate matter in intravenous solutions using the Coulter counter.
    Blaug SM; Sarabia RE
    Bull Parenter Drug Assoc; 1975; 29(2):74-88. PubMed ID: 1120215
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of repeated puncture on the particulate matter contamination of multidose vials as assessed by the Industrial Model B Coulter Counter.
    Edirimanasinghe SM; Lemberger AP; Perrin JH
    Acta Pharm Suec; 1968 Nov; 5(5):501-8. PubMed ID: 5732570
    [No Abstract]   [Full Text] [Related]  

  • 50. [Safety of drugs: problems concerning container closures made of elastomer material for powdered and injectable drugs].
    Colombo A; Zoni G
    Boll Chim Farm; 1977 Nov; 116(11):635-6. PubMed ID: 615637
    [No Abstract]   [Full Text] [Related]  

  • 51. [Particulate contamination of amino acid solutions for parenteral use].
    Ferrari F; Bonferoni MC; Zamella C; La Manna A; Verrengio B; Pedroni M; Omodei-Sale A
    Boll Chim Farm; 1991 Nov; 130(10):402-8. PubMed ID: 1805875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of rubber closures with powders for parenteral administration.
    Jaehnke RW; Kreuter J; Ross G
    J Parenter Sci Technol; 1990; 44(5):282-8. PubMed ID: 2250205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Counting of particulate matter in parenteral solutions. I. Survey of the literature.
    Lines RW
    Bull Parenter Drug Assoc; 1967; 21(4):113-7. PubMed ID: 4859718
    [No Abstract]   [Full Text] [Related]  

  • 54. Particulate contamination of parenterals.
    Dando W
    Anesth Prog; 1979; 26(5):127-8. PubMed ID: 298460
    [No Abstract]   [Full Text] [Related]  

  • 55. Particulate contamination of intravenous fluids.
    Garvan JM; Gunner BW
    Br J Clin Pract; 1971 Mar; 25(3):119-21. PubMed ID: 5555236
    [No Abstract]   [Full Text] [Related]  

  • 56. Particulate inspection of parenteral products: an assessment.
    Knapp JZ; Kushner HK; Abramson LR
    J Parenter Sci Technol; 1981; 35(4):176-85. PubMed ID: 7277132
    [No Abstract]   [Full Text] [Related]  

  • 57. Standards for particulate matter in all parenteral drug products.
    Jeffrey LP; Pinkus TF
    Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053
    [No Abstract]   [Full Text] [Related]  

  • 58. Parenteral packaging waste reduction.
    Baetz BW
    Can J Hosp Pharm; 1990 Aug; 43(4):179-81, 195. PubMed ID: 10105986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Particulate contamination of solutions for intrathecal use.
    Pinnock CA
    Ann R Coll Surg Engl; 1984 Nov; 66(6):423. PubMed ID: 6548889
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals.
    Bernuzzi M; Raggi P; Montanari L; Pregnolato F; Pavanetto F
    J Parenter Sci Technol; 1993; 47(5):265-9. PubMed ID: 8263664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.